Neurogene Inc.
NGNE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404644
No open-market purchases or sales by Neurogene Inc. insiders were filed in the last 90 days; 111 institutions reported holding it in 13F filings for Q2 2026, worth $544.4M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Neurogene Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 66 | 1 | 86 | +21 |
| Shares | 13.3M | 1.39M | 13.8M | +1.98M (+16.7%) |
| Value | $482.7M | $50.8M | $581.1M | +$149.1M (+34.5%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held Neurogene Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 1,371,879 | $57.6M | 0.00% |
| Siren, L.L.C. | 175,898 | $7.38M | 0.37% |
| Woodline Partners LP | 83,088 | $3.49M | 0.03% |
| Jennison Associates LLC | 78,650 | $3.30M | 0.00% |
| Alliancebernstein L.P. | 65,119 | $2.73M | 0.00% |
| Wellington Management Group LLP | 18,290 | $767.4K | 0.00% |
| Octagon Capital Advisors LP | 15,000 | $629.4K | 0.10% |
| Tower Research Capital LLC (TRC) | 8,396 | $352.3K | 0.01% |
| Franklin Resources Inc | 7,050 | $350.7K | 0.00% |
| Jane Street Group, LLC | 7,717 | $323.8K | 0.00% |
| MetLife Investment Management | 6,054 | $254.0K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 5,696 | $239.0K | 0.00% |
| Squarepoint Ops LLC | 4,980 | $209.0K | 0.00% |
| SG Americas Securities, LLC | 3,576 | $150.0K | 0.00% |
| Atticus Wealth Management, LLC | 437 | $18.3K | 0.01% |
| Acadian Asset Management LLC | 449 | $18.0K | 0.00% |
| Truvestments Capital LLC | 46 | $1.93K | 0.00% |
| Comerica Bank | 40 | $1.68K | 0.00% |
| Nisa Investment Advisors, LLC | 26 | $1.09K | 0.00% |
| Sterling Capital Management LLC | 22 | $923 | 0.00% |
| Signaturefd, LLC | 22 | $923 | 0.00% |
| Smartleaf Asset Management LLC | 10 | $403 | 0.00% |
| CWM, LLC | 4 | $0 | 0.00% |
Sold out (2)
Institutions that held Neurogene Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Qube Research & Technologies Ltd | 5,135 | $186.9K |
| Huntington National Bank | 10 | $364 |
Not filed for Q3 2024 yet (1)
Institutions that held Neurogene Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,394,714 | $50.8M |